Global Diabetic Therapeutic Market Size, Status and Forecast 2019-2025

The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
The report identifies the increasing focus on the self-management of diabetes to be one of the major factors that will have a positive impact on the growth of this market in the coming years. With the recent years witnessing an increase in number of people diagnosed with type 1 diabetes, there has been considerable increase in the adoption of insulin delivery systems. Focusing on skipping the need to schedule appointments and reduce expenses for clinical visits, increases the adoption of insulin delivery systems, where individuals use insulin injections at home under the guidance of a physician. This led to the introduction of insulin pens, pumps, and jet injectors, which, in turn, will drive the growth of the diabetic therapeutics market.
Characterized by the presence of numerous small and large-scale vendors, the diabetes treatment market appears to be highly competitive. The market is dominated by the major players such as AstraZeneca, Novo Nordisk, Merck, Eli Lilly, and Sanofi who are competing against each other to lead the market. The market also consists of a number of local manufacturers in various countries and will also witness the entry of several new players, which will further intensify the level of competition in the market. To increase their revenue shares and improve market position, vendors are focusing on strategic alliances which will help them in marketing and manufacturing drugs.
In terms of geographical regions, the Americas will be the major revenue contributor to the diabetic therapeutics market throughout the predicted period. The increasing prevalence of diabetes in countries such as the US, which provides opportunities for vendors to develop new, more efficient, and safer drugs will be the major factor driving market growth in this segment.
In 2018, the global Diabetic Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Therapeutic development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
Amgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
Bristol-Myers Squibb

Market segment by Type, the product can be split into
Type 1
Type 2
Gestational

Market segment by Application, split into
Insulin therapies
Non-insulin therapies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Type 1
1.4.3 Type 2
1.4.4 Gestational
1.5 Market by Application
1.5.1 Global Diabetic Therapeutic Market Share by Application (2014-2025)
1.5.2 Insulin therapies
1.5.3 Non-insulin therapies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Therapeutic Market Size
2.2 Diabetic Therapeutic Growth Trends by Regions
2.2.1 Diabetic Therapeutic Market Size by Regions (2014-2025)
2.2.2 Diabetic Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Diabetic Therapeutic Market Size by Manufacturers
3.1.1 Global Diabetic Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Diabetic Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Diabetic Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Therapeutic Key Players Head office and Area Served
3.3 Key Players Diabetic Therapeutic Product/Solution/Service
3.4 Date of Enter into Diabetic Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Therapeutic Market Size by Type (2014-2019)
4.2 Global Diabetic Therapeutic Market Size by Application (2014-2019)

5 United States
5.1 United States Diabetic Therapeutic Market Size (2014-2019)
5.2 Diabetic Therapeutic Key Players in United States
5.3 United States Diabetic Therapeutic Market Size by Type
5.4 United States Diabetic Therapeutic Market Size by Application

6 Europe
6.1 Europe Diabetic Therapeutic Market Size (2014-2019)
6.2 Diabetic Therapeutic Key Players in Europe
6.3 Europe Diabetic Therapeutic Market Size by Type
6.4 Europe Diabetic Therapeutic Market Size by Application

7 China
7.1 China Diabetic Therapeutic Market Size (2014-2019)
7.2 Diabetic Therapeutic Key Players in China
7.3 China Diabetic Therapeutic Market Size by Type
7.4 China Diabetic Therapeutic Market Size by Application

8 Japan
8.1 Japan Diabetic Therapeutic Market Size (2014-2019)
8.2 Diabetic Therapeutic Key Players in Japan
8.3 Japan Diabetic Therapeutic Market Size by Type
8.4 Japan Diabetic Therapeutic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Therapeutic Market Size (2014-2019)
9.2 Diabetic Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Therapeutic Market Size by Type
9.4 Southeast Asia Diabetic Therapeutic Market Size by Application

10 India
10.1 India Diabetic Therapeutic Market Size (2014-2019)
10.2 Diabetic Therapeutic Key Players in India
10.3 India Diabetic Therapeutic Market Size by Type
10.4 India Diabetic Therapeutic Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Therapeutic Market Size (2014-2019)
11.2 Diabetic Therapeutic Key Players in Central & South America
11.3 Central & South America Diabetic Therapeutic Market Size by Type
11.4 Central & South America Diabetic Therapeutic Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Therapeutic Introduction
12.1.4 AstraZeneca Revenue in Diabetic Therapeutic Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Therapeutic Introduction
12.2.4 Eli Lilly Revenue in Diabetic Therapeutic Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Therapeutic Introduction
12.3.4 Merck Revenue in Diabetic Therapeutic Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Therapeutic Introduction
12.4.4 Novo Nordisk Revenue in Diabetic Therapeutic Business (2014-2019)
12.4.5 Novo Nordisk Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Therapeutic Introduction
12.5.4 Sanofi Revenue in Diabetic Therapeutic Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Therapeutic Introduction
12.6.4 AbbVie Revenue in Diabetic Therapeutic Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Actelion Pharmaceuticals
12.7.1 Actelion Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Therapeutic Introduction
12.7.4 Actelion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)
12.7.5 Actelion Pharmaceuticals Recent Development
12.8 Adocia
12.8.1 Adocia Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Therapeutic Introduction
12.8.4 Adocia Revenue in Diabetic Therapeutic Business (2014-2019)
12.8.5 Adocia Recent Development
12.9 Aegerion Pharmaceuticals
12.9.1 Aegerion Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Therapeutic Introduction
12.9.4 Aegerion Pharmaceuticals Revenue in Diabetic Therapeutic Business (2014-2019)
12.9.5 Aegerion Pharmaceuticals Recent Development
12.10 Akros Pharma
12.10.1 Akros Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Therapeutic Introduction
12.10.4 Akros Pharma Revenue in Diabetic Therapeutic Business (2014-2019)
12.10.5 Akros Pharma Recent Development
12.11 Alnylam Pharmaceuticals
12.12 Amarin
12.13 Amgen
12.14 Amicus Therapeutics
12.15 Arbutus Biopharma
12.16 Arena Pharmaceuticals
12.17 Astellas Pharma
12.18 Atheronova
12.19 Biodel
12.20 BioMarin
12.21 Bionaturis
12.22 Biosidus
12.23 Biospherics
12.24 Boehringer Ingelheim
12.25 Bristol-Myers Squibb

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

1.1 Methodology/Research Approach

Our research methodology implements a mix of primary as well as secondary research. Our projects are initiated with secondary research, where we refer to a variety of sources including trade databases; government published documents, investor presentations, company annual reports, white papers, and paid databases.

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

Post the initial data mining stage, we gather our findings and analyse them, filtering out relevant insights. These are evaluated across teams and by our in-house SMEs. Along with data mining, we also initiate the primary research phase in which we interact with companies operating within the market space.

To evaluate the wholeness of the market, we interact (via email or telephone) with players who are responsible in adding value to the final product. Additionally, we interact with related industries to understand the external factors that can drive/hamper a market. We also make it a point to evaluate various economic parameters, which typically, have an impact on the purchasing choices of individuals as well as companies.

Post these stages, data are cross-verified with the companies that operate in a market space. It is important for us to study these companies in detail, to understand their existing performance and future strategies which will define the market in the coming years.

All this data is collected and evaluated by our analysts. Post the preparation of the report and data analysis, the findings are presented to our in-house experts who then eliminate discrepancies (if any).

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares splits, and breakdowns have been determined using secondary sources and verified through primary sources.

1.2 Data Source

1.2.1 Secondary Sources

In the secondary research process, various secondary sources, such as D&B Hoovers, Bloomberg BusinessWeek, and Factiva, have been referred to, for identifying and collecting information for this study. Secondary sources included annual reports, press releases, and investor presentations of companies; whitepapers, certified publications, and articles by recognized authors; gold standard and silver standard websites; regulatory bodies; trade directories; and databases.

List of secondary sources include but are not limited to:

  • Academic Journals
  • Census.gov
  • Bloomberg
  • Company Annual Report
  • Hoovers

1.2.1.1 Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

1.2.2 Primary Sources

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

  • Market leading companies
  • Raw material suppliers
  • Product distributors
  • Buyers

The key objectives of primary research are as follows:

  • To validate our data in terms of accuracy and acceptability
  • To gain an insight in to the current market and future expectations

1.2.3 Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

  • Market drivers and restrains, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2026

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

1.2.4 Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above, the market was split into several segments and sub segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying several factors and trends from both the demand and supply sides.

1.2.5 Report Objectives

  • To define, describe, and forecast the market by segmentations, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze the sub-segments with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide the competitive landscape of the market
  • To forecast the revenues of the market segments with respect to the major regions, such as North America, Europe, Asia Pacific (APAC), and RoW
  • To profile the key players and comprehensively analyze their recent developments and positioning in the market
  • To analyze competitive developments, such as mergers and acquisitions, new product developments, and Research and Development (R&D) activities, in the market
Purchase
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150

Purchase Report

Purchase

Download Category:

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why SMR?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements